Piofag is a sophisticated biological preparation containing a polyvalent mixture of sterile filtrates of bacterial phagolysates. It represents the pinnacle of phage therapy—a highly specific medical approach that utilizes naturally occurring viruses (bacteriophages) to target and destroy pathogenic bacteria. Unlike broad-spectrum antibiotics, Piofag acts with surgical precision, lysing only the harmful bacteria responsible for the infection while leaving the body's beneficial commensal flora intact. This makes it an invaluable tool in treating antibiotic-resistant strains and chronic, deep-seated purulent-inflammatory processes across various medical disciplines, from surgery to pediatrics.
Piofag is a clear, yellow-to-greenish liquid solution. Its composition is a complex biological cocktail:
Active Substances: Sterile purified filtrates of phagolysates of the following bacteria: Staphylococcus, Streptococcus, Proteus (mirabilis and vulgaris), Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Excipients: The solution is stabilized with 8-hydroxyquinoline sulfate or Merthiolate (preservative) to maintain the biological activity of the viral particles within a physiological saline environment.
The mechanism of action of Piofag is based on the lytic cycle of bacteriophages.
Adsorption: The specific phage particles in the solution recognize and bind to receptors on the surface of the target bacterial cell.
Penetration: The phage injects its genetic material (DNA) into the bacterial cell.
Replication: The bacterial cell's machinery is hijacked to produce hundreds of new bacteriophages.
Lysis: The bacterial cell membrane ruptures (lyses), releasing the newly formed phages to infect neighboring pathogenic bacteria. This self-amplifying process continues as long as the specific host bacteria are present. Crucially, because phages are highly host-specific, they do not affect human cells or the good bacteria in the gut and on the skin, preventing side effects common to antibiotics like dysbiosis or secondary candidiasis.
Piofag is indicated for the treatment and prophylaxis of a wide range of infections caused by the aforementioned pathogens:
Otolaryngology: Sinusitis, otitis media, tonsillitis, pharyngitis, and laryngitis.
Respiratory Tract: Bronchitis, pneumonia, and pleurisy.
Surgery: Infected wounds, burns, abscesses, phlegmon, furuncles, carbuncles, and osteomyelitis.
Urogenital Infections: Cystitis, pyelonephritis, urethritis, endometritis, and salpingo-oophoritis.
Gastroenterology: Enterocolitis, cholecystitis, and intestinal dysbiosis (when caused by pathogenic E. coli or Proteus).
Pediatrics: Omphalitis (umbilical infection) and pyoderma in newborns.
Hypersensitivity: There are no known absolute contraindications to the use of bacteriophages, other than potential sensitivity to the preservative components of the solution.
Note: Unlike antibiotics, Piofag does not have toxic effects on the liver or kidneys.
The dosage and method of administration depend on the location of the infection:
Topical (Wounds/Abscesses): After surgical drainage, the solution is applied via dressings or irrigation. For abscesses, a volume slightly less than the evacuated pus is injected.
ENT/Respiratory: Used as drops (2-10 ml) or for rinsing/nebulization 1-3 times daily.
Urogenital: Introduced into the bladder via catheter (20-50 ml) or into the vagina/uterus (5-10 ml).
Oral (Intestinal): Taken 1 hour before meals. Adults: 20-30 ml; Children 3-8 years: 15-20 ml; Infants: 5-10 ml.
Rectal (Enemas): Often combined with oral use for systemic GI treatment.
Before use, the bottle should be shaken and inspected. The solution must be clear and free of sediment. To maintain sterility when using small portions, it is recommended to extract the liquid through the rubber stopper using a sterile syringe rather than opening the bottle completely.
Bacteriophage therapy is exceptionally safe. No significant adverse reactions have been reported. In very rare cases, a local transient redness or slight increase in temperature may occur due to the rapid release of bacterial endotoxins during mass lysis; this is generally considered a sign of the medication's effectiveness.
Sterility: The product contains no powerful preservatives; therefore, once the bottle's integrity is compromised, it must be stored under strict refrigeration and handled with aseptic techniques.
Compatibility: Piofag can be used concurrently with antibiotics, anti-inflammatory drugs, and other medications. In many cases, it enhances the effect of antibiotic therapy.
Pregnancy and Lactation: Since the product is non-toxic and acts locally/specifically, it is considered safe for use during pregnancy and breastfeeding under medical supervision.
Critical Requirement: Must be stored in a dry, dark place at a temperature between 2°C and 8°C (refrigerator).
Transport: May be transported at temperatures up to 25°C for no longer than 30 days, but must be returned to cold storage immediately.
Shelf Life: 2 years from the date of manufacture.
Warning: If the solution becomes cloudy or shows flakes, it must be discarded.
There are no reviews for this product.